Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$0.0 - $0.0 $0 - $0
-38,864 Reduced 27.58%
102,049 $1.65 Million
Q2 2021

Aug 16, 2021

BUY
$0.0 - $27.0 $0 - $969,651
35,913 Added 34.2%
140,913 $1.83 Million
Q1 2021

May 14, 2021

SELL
$22.6 - $31.0 $1.01 Million - $1.39 Million
-44,892 Reduced 29.95%
105,000 $2.03 Million
Q4 2020

Feb 16, 2021

BUY
$12.85 - $19.95 $1.93 Million - $2.99 Million
149,892 New
149,892 $3.13 Million

Others Institutions Holding VINC

About Vincerx Pharma, Inc.


  • Ticker VINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,189,800
  • Market Cap $3.18M
  • Description
  • Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...
More about VINC
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.